MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

04 MAR 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks MilliporeSigma’s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Burlington, Massachusetts, March 4, 2019 – MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed... Read more

Lexogen Launches CORALL – The New Stranded Whole Transcriptome Library Prep Kit for Illumina®

Vienna, Austria, February 28, 2019 / PRNewswire/ – Today Lexogen announced the launch of the CORALL Total RNA-Seq Library Prep Kit. This new all-in-one library prep kit can be used for all whole transcriptome analysis applications such as differential expression, isoform quantification, single nucleotide polymorphism (SNP), and mutation detection. “RNA-Seq library preparation protocols are still plagued by... Read more

Beckman Coulter Life Sciences Enters Liquid Biopsy Partnership with Apostle Inc.

Indianapolis, Indiana (February 28, 2019) – At the Advances in Genome Biology and Technology (AGBT) General Meeting*, Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company. As cfDNA workflows move beyond theoretical and into human health applications, Apostle’s industry leading chemistry... Read more

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. Barclays Global Healthcare Conference in Miami Beach, FLWednesday, March 13, 2019 at 11:15 am Eastern Time The live webcast can be accessed in the Investor Relations section of Illumina’s web... Read more

Agilent Announces New Library Preparation System for Next Generation Sequencing

Agilent Announces New Library Preparation System for Next Generation Sequencing Fully automated Magnis system delivers reproducible results for molecular laboratories SANTA CLARA, Calif., February 28, 2019 Agilent Technologies, Inc. (NYSE: A) today announced a new next-generation sequencing (NGS) library preparation system designed to easily run complex DNA sequencing assays with the press of a button.... Read more

Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference

MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced its participation in this week’s Advances in Genome Biology & Technology (AGBT) General Meeting taking place February 27-March 2 in Marco Island, FL.Several talks by PacBio customers will... Read more

Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT Conference

MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced its participation in this week’s Advances in Genome Biology & Technology (AGBT) General Meeting taking place February 27-March 2 in Marco Island, FL.Several talks by PacBio customers will... Read more

MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

News Release February 19, 2019 Your Contact:Media Relationskaren.tiano@emdmillipore.comPhone: +1 978 495 0093 Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage Burlington, Massachusetts, February 19, 2019 — MilliporeSigma, a leader in genome editing, today announced that the United States Patent and... Read more

Merck KGaA, Darmstadt, Germany Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

19 FEB 2019 | DARMSTADT, GERMANY Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage  Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has issued... Read more

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response

Date: 02/14/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug... Read more